Literature DB >> 6215032

Transitions in human atrial and ventricular myosin light-chain isoenzymes in response to cardiac-pressure-overload-induced hypertrophy.

P Cummins.   

Abstract

1. The light-chain subunits of human atrial and ventricular cardiac muscle were examined by two-dimensional polyacrylamide-gel electrophoresis and limited proteolytic digestion. The light-chain patterns in the normal right and left atria were identical. 2. Myosin preparations isolated from right or left atria that had been subjected to cardiac-pressure-overload-induced hypertrophy also contained ventricular light-chain subunits. These were identified by peptide mapping in sodium dodecyl sulphate. 3. Ventricular light chain-2 was the major species in hypertrophied atria, although light chain-1 subsequently appeared in severe pressure-overload-hypertrophied cases. Evidence is presented for the existence of more than one form of ventricular light chain-2. 4. The transition from atrial to ventricular myosin light chains correlated with the degree of pressure-overload hypertrophy in 83 examples of surgically excised atria. 5. The adult atrial light chain-1 was shown to be homologous to the human foetal ventricular light chain-1 [Price, Littler & Cummins (1980) Biochem. J. 191, 571-580] by peptide mapping. 6. A scheme of atrial/ventricular myosin light-chain isoenzyme transitions is discussed in relation to changing contractile properties in cardiac muscle, together with implications for the role of light-chain subunits.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6215032      PMCID: PMC1158463          DOI: 10.1042/bj2050195

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Effects of N-ethylmaleimide on the ATPase activities of cardiac myosin from thyrotoxic rabbits.

Authors:  T Katagiri; A S Freedberg; E Morkin
Journal:  Life Sci       Date:  1975-04-01       Impact factor: 5.037

2.  A new cardiac myosin characterized from the canine atria.

Authors:  L Long; F Fabian; D T Mason; J Wikman-Coffelt
Journal:  Biochem Biophys Res Commun       Date:  1977-06-06       Impact factor: 3.575

3.  Atrial and ventricular cardiac myosins contain different heavy chain species.

Authors:  I L Flink; J H Rader; S K Banerjee; E Morkin
Journal:  FEBS Lett       Date:  1978-10-01       Impact factor: 4.124

4.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

5.  Thyroidal trophic influence on skeletal muscle myosin.

Authors:  D Ianuzzo; P Patel; V Chen; P O'Brien; C Williams
Journal:  Nature       Date:  1977-11-03       Impact factor: 49.962

Review 6.  Interrelations of the proliferation and differentiation processes during cardiact myogenesis and regeneration.

Authors:  P P Rumyantsev
Journal:  Int Rev Cytol       Date:  1977

7.  Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.

Authors:  D W Cleveland; S G Fischer; M W Kirschner; U K Laemmli
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

8.  Phosphorylation of the light-chain components of myosin from cardiac and red skeletal muscles.

Authors:  N Frearson; S V Perry
Journal:  Biochem J       Date:  1975-10       Impact factor: 3.857

9.  Effect of the thyroid state on the enzymatic characteristics of cardiac myosin. A difference in behavior of rat and rabbit cardiac myosin.

Authors:  Y Yazaki; M S Raben
Journal:  Circ Res       Date:  1975-01       Impact factor: 17.367

10.  The transformation of myosin in cross-innervated rat muscles.

Authors:  M Bárány; R I Close
Journal:  J Physiol       Date:  1971-03       Impact factor: 5.182

View more
  31 in total

1.  Construction of a human ventricular cDNA library and characterization of a beta myosin heavy chain cDNA clone.

Authors:  M A Jandreski; C C Liew
Journal:  Hum Genet       Date:  1987-05       Impact factor: 4.132

2.  Molecular cloning and characterization of human cardiac alpha- and beta-form myosin heavy chain complementary DNA clones. Regulation of expression during development and pressure overload in human atrium.

Authors:  M Kurabayashi; H Tsuchimochi; I Komuro; F Takaku; Y Yazaki
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

3.  Heterogeneity of beta-type myosin isozymes in the human heart and regulational mechanisms in their expression. Immunohistochemical study using monoclonal antibodies.

Authors:  H Tsuchimochi; M Kuro-o; H Koyama; M Kurabayashi; M Sugi; F Takaku; S Furuta; Y Yazaki
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

Review 4.  The myosin alkali light chain proteins and their genes.

Authors:  P J Barton; M E Buckingham
Journal:  Biochem J       Date:  1985-10-15       Impact factor: 3.857

Review 5.  Contractile proteins in muscle disease.

Authors:  P Cummins
Journal:  J Muscle Res Cell Motil       Date:  1983-02       Impact factor: 2.698

6.  Myosin light chains of avian and mammalian slow muscles: peptide mapping of 2S light chains.

Authors:  L Dalla Libera; R Betto; R Lodolo; U Carraro
Journal:  J Muscle Res Cell Motil       Date:  1984-08       Impact factor: 2.698

7.  Management of aortic left ventricular tunnel.

Authors:  P Ribeiro; L B Bun-Tan; C M Oakley
Journal:  Br Heart J       Date:  1985-09

8.  Two different forms of beta myosin heavy chain are expressed in human striated muscle.

Authors:  M A Jandreski; M J Sole; C C Liew
Journal:  Hum Genet       Date:  1987-10       Impact factor: 4.132

9.  Expression of myosin light chains during fetal development of human skeletal muscle.

Authors:  F Pons; A Damadei; J J Leger
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

10.  Further studies on the effects of myosin P-light chain phosphorylation on contractile properties of skinned cardiac fibres.

Authors:  I Morano; H Arndt; C Bächle-Stolz; J C Rüegg
Journal:  Basic Res Cardiol       Date:  1986 Nov-Dec       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.